Walleye Trading
SGMO

Walleye Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Walleye Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-100
Closed -$1K – 5609
2022
Q1 		$1K Sell
100
-9,500
-99% -$56.5K ﹤0.01% 5232
2021
Q4 		$72K Sell
9,600
-16,000
-63% -$139K ﹤0.01% 4525
2021
Q3 		$231K Hold
25,600
– – ﹤0.01% 3712
2021
Q2 		$306K Buy
25,600
+15,600
+156% +$177K ﹤0.01% 3466
2021
Q1 		$125K Buy
10,000
+8,400
+525% +$113K ﹤0.01% 3977
2020
Q4 		$25K Buy
+1,600
New +$18.7K ﹤0.01% 4349
2019
Q3 		– Sell
-18,900
Closed -$204K – 4387
2019
Q2 		$204K Buy
18,900
+9,600
+103% +$102K ﹤0.01% 2922
2019
Q1 		$89K Buy
+9,300
New +$95K ﹤0.01% 3510
2018
Q4 		– Sell
-11,600
Closed -$197K – 5237
2018
Q3 		$197K Buy
+11,600
New +$176K ﹤0.01% 3766
2018
Q2 		– Sell
-5,000
Closed -$95K – 4865
2018
Q1 		$95K Buy
+5,000
New +$107K ﹤0.01% 3923

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Trading's SGMO Position: Q2 2022 in Review

Walleye Trading sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 9,715 shares — an estimated $56K sold.

Walleye Trading first reported a position in SGMO in Q1 2018 and held it in 3 quarters. The position peaked at $281K in Q4 2020. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • Walleye Trading reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 9,715 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $56K.
  • Walleye Trading first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 3 quarters.
  • Walleye Trading's SANGAMO THERAPEUTICS INC position peaked at $281K in Q4 2020.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.